Please Wait
Applying Filters...
menu
    • menu
    Porton Pharma solutions-PSE
    News
    Porton And Genentech Publish Breakthrough In Crystallization Research

    05 Jul 2024

    // PRESS RELEASE

    Porton Experts Join U Of Perugia's PRO-API Program For Green Chemistry

    29 Jun 2024

    // PRESS RELEASE

    Porton J-STAR Partners With ETC On Co-Processing Platform Tech Development

    28 Jun 2024

    // PRESS RELEASE

    Data Compilation
    #PharmaFlow

    Porton Pharma Solutions

    Contact Supplier

    Website

    PackExpo

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    Menu

    Porton Pharma Solutions

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    Key Products KEY PRODUCTS

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1(1R,2R)-2-amino-6-(4-nitrophenyl)-1-phenylhex-5- yn-1-olhydrochloride

    02 1(1R,5S)-3-ethylbicyclo[3.2.0]hept-3- en-6-one

    03 1(2-(((1-chloroethoxy)carbonyl)(met hyl)amino)pyridin-3- yl)methyl N-(tert-butoxycarbonyl)-N-methylglycinate

    04 1(2-(methylamino)pyridin-3- yl)methyl 2-(tertbutoxycarbonyl(methyl)amino)acet ate

    05 1(2-chloro-5-iodophenyl)(4- fluorophenyl)methanone

    06 1(2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy- 2-Methyl-4-(1H-1,2,4-triazol-1-yl)thiobutyraMide

    07 1(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4- chloro-3-(4- ethoxybenzyl)phenyl)tetrah ydro-2H-pyran-3,4,5-triyltriacetate

    08 1(2R,3S)-2-(2,5-difluorophenyl)-3-methyl-2- [(1H-1,2,4-triazol-1-yl)- methyl]-oxirane

    09 1(3R,4S,5R,6R)-3,4,5-tris(triMethylsilyloxy)-6- ((triMethylsilyloxy)Methyl)t etrahydro-2H-pyran-2-one

    10 1(3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan

    11 1(3S,5S,6R)-3-amino-6-methyl-5-phenyl-1-(2,2,2- trifluoroethyl)piperidin-2- one

    12 1(3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2- trifluoroethyl)piperidine-3- aminium 4-nitrobenzoate

    13 1(6S)-2'-oxo-1',2',5,7- tetrahydrospiro[cyclopenta[b]pyridi ne-6,3'-pyrrolo[2,3-b]pyridine]-3- carboxylic acid

    14 1(6S)-4,6,7,8-tetrahydro-4- oxo-Pyrrolo[1,2- a]pyriMidine-6-carboxylic acid

    15 1(S)-3-(4-(5-bromo-2-chlorobenzyl)phenoxy)tetra hydrofuran

    16 5(S)-3-hydroxytetyrahydrofuran

    17 11-(1-methylpiperidin-4- yl)piperazine hydrochloride

    18 11-Methyl-4-(6- Aminopyridin-3- Yl)Piperazine

    19 12-((3bS,4aR)-5,5-difluoro-3- (trifluoromethyl)-3b,4,4a,5- tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetic acid

    20 12-Amino-1,3-propanediol

    21 12-amino-N-(2,2,2-trifluoroethyl)acetamide hydrochloride

    22 12-oxo-1-(4-piperidinyl)-2,3- dihydro-1H-imidazo[4,5- b]pyridine dihydrochloride

    23 13-(piperidin-4-yl)quinolin-2(1H)-one hydrochloride

    24 14-(2-Bromoacetyl)benzonitrile

    25 14-amino-2-fluoro-N- methylbenzamide

    26 15-((4-ethylpiperazin-1-yl)methyl)pyridin-2-amine

    27 15-bromo-2-chloro-4'- ethoxydiphenylmethane

    28 19-((triisopropylsilyl)oxy)-6,7,8,9- tetrahydro-5Hcyclohepta[b]pyridin-5-one hydrochloride

    29 1Acetoxy Empagliflozin

    30 1Methyl (2R)-2-amino-3-(7- methyl-1H-indazol-5- yl)propanoate dihydrochloride

    31 1Methyl (3R)-3-(tert- butyldimethylsilyloxy)-5- oxo-6- triphenylphosphoranylidene hexanoate

    32 1Moc-L-tert-Leucine

    33 1Sodium(S)-4-oxo-4,6,7,8- tetrahydropyrrolo[1,2- a]pyrimidine-6-carboxylate

    34 1trans-2-(4-acetamidocyclohexyl)acetic acid

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    Contact SupplierContact Supplier
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothPorton Pharma Solutions: Value creation via innovation & discovery through technical platforms.
    Contact Supplier Contact Supplier
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    (1R,2R)-2-amino-6-(4-nitrophenyl)-1-phenylhex-5- yn-1-olhydroc...

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    1628836-08-7
    Vibegron
    Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in S...
    Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities are located in China, Slovenia, the US, Belgium, Switzerland, Denmark, with more than 6000 employees worldwide. Porton leads the way with its excellent CDMO services, but also supplies APIs & intermediates for the treatment of critical diseases such as HIV/AIDS, diabetes, cancer, & influenza. Our Process Technology Centers & WHO/USFDA/EMA/PDMA/NMPA-inspected Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets.
    Porton Company Banner

    01

    (1R,2R)-2-amino-6-(4-nitrophenyl)-1-phenylhex-5- yn-1-olhydrochloride

    China
    2024 ACI Convention
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothPorton Pharma Solutions: Value creation via innovation & discovery through technical platforms.

    Porton Pharma Solutions

    (1R,2R)-2-amino-6-(4-nitrophenyl)-1-phenylhex-5- yn-1-olhydroc...

    CAS Number : 1628836-08-7

    End Use API : Vibegron

    About the Company : Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchan...

    Porton Company Banner

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothPorton Pharma Solutions: Value creation via innovation & discovery through technical platforms.
    Contact Supplier Contact Supplier
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    (1R,5S)-3-ethylbicyclo[3.2.0]hept-3- en-6-one

    Intermediate Web Link

    Market Place

    1235479-61-4
    Mirogabalin Besylate
    Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in S...
    Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities are located in China, Slovenia, the US, Belgium, Switzerland, Denmark, with more than 6000 employees worldwide. Porton leads the way with its excellent CDMO services, but also supplies APIs & intermediates for the treatment of critical diseases such as HIV/AIDS, diabetes, cancer, & influenza. Our Process Technology Centers & WHO/USFDA/EMA/PDMA/NMPA-inspected Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets.
    Porton Company Banner

    02

    (1R,5S)-3-ethylbicyclo[3.2.0]hept-3- en-6-one

    China
    2024 ACI Convention
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothPorton Pharma Solutions: Value creation via innovation & discovery through technical platforms.

    Porton Pharma Solutions

    (1R,5S)-3-ethylbicyclo[3.2.0]hept-3- en-6-one

    CAS Number : 1235479-61-4

    End Use API : Mirogabalin Besylate

    About the Company : Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchan...

    Porton Company Banner

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothPorton Pharma Solutions: Value creation via innovation & discovery through technical platforms.
    Contact Supplier Contact Supplier
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    (2-(((1-chloroethoxy)carbonyl)(met hyl)amino)pyridin-3- yl)met...

    Intermediate Web Link

    Market Place

    338990-31-1
    Isavuconazonium Sulfate
    Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in S...
    Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities are located in China, Slovenia, the US, Belgium, Switzerland, Denmark, with more than 6000 employees worldwide. Porton leads the way with its excellent CDMO services, but also supplies APIs & intermediates for the treatment of critical diseases such as HIV/AIDS, diabetes, cancer, & influenza. Our Process Technology Centers & WHO/USFDA/EMA/PDMA/NMPA-inspected Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets.
    Porton Company Banner

    03

    (2-(((1-chloroethoxy)carbonyl)(met hyl)amino)pyridin-3- yl)methyl N-(tert-butoxycarbonyl)-N-methylglycinate

    China
    2024 ACI Convention
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothPorton Pharma Solutions: Value creation via innovation & discovery through technical platforms.

    Porton Pharma Solutions

    (2-(((1-chloroethoxy)carbonyl)(met hyl)amino)pyridin-3- yl)met...

    CAS Number : 338990-31-1

    End Use API : Isavuconazonium Sulfate

    About the Company : Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchan...

    Porton Company Banner

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothPorton Pharma Solutions: Value creation via innovation & discovery through technical platforms.
    Contact Supplier Contact Supplier
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    (2-(methylamino)pyridin-3- yl)methyl 2-(tertbutoxycarbonyl(met...

    Intermediate Web Link

    Market Place

    1180002-01-0
    Isavuconazonium Sulfate
    Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in S...
    Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities are located in China, Slovenia, the US, Belgium, Switzerland, Denmark, with more than 6000 employees worldwide. Porton leads the way with its excellent CDMO services, but also supplies APIs & intermediates for the treatment of critical diseases such as HIV/AIDS, diabetes, cancer, & influenza. Our Process Technology Centers & WHO/USFDA/EMA/PDMA/NMPA-inspected Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets.
    Porton Company Banner

    04

    (2-(methylamino)pyridin-3- yl)methyl 2-(tertbutoxycarbonyl(methyl)amino)acet ate

    China
    2024 ACI Convention
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothPorton Pharma Solutions: Value creation via innovation & discovery through technical platforms.

    Porton Pharma Solutions

    (2-(methylamino)pyridin-3- yl)methyl 2-(tertbutoxycarbonyl(met...

    CAS Number : 1180002-01-0

    End Use API : Isavuconazonium Sulfate

    About the Company : Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchan...

    Porton Company Banner

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothPorton Pharma Solutions: Value creation via innovation & discovery through technical platforms.
    Contact Supplier Contact Supplier
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    (2-chloro-5-iodophenyl)(4- fluorophenyl)methanone

    Intermediate Web Link

    Market Place

    915095-86-2
    Empagliflozin
    Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in S...
    Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities are located in China, Slovenia, the US, Belgium, Switzerland, Denmark, with more than 6000 employees worldwide. Porton leads the way with its excellent CDMO services, but also supplies APIs & intermediates for the treatment of critical diseases such as HIV/AIDS, diabetes, cancer, & influenza. Our Process Technology Centers & WHO/USFDA/EMA/PDMA/NMPA-inspected Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets.
    Porton Company Banner

    05

    (2-chloro-5-iodophenyl)(4- fluorophenyl)methanone

    China
    2024 ACI Convention
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothPorton Pharma Solutions: Value creation via innovation & discovery through technical platforms.

    Porton Pharma Solutions

    (2-chloro-5-iodophenyl)(4- fluorophenyl)methanone

    CAS Number : 915095-86-2

    End Use API : Empagliflozin

    About the Company : Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchan...

    Porton Company Banner

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothPorton Pharma Solutions: Value creation via innovation & discovery through technical platforms.
    Contact Supplier Contact Supplier
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    (2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy- 2-Methyl-4-(1H-1,2,4...

    Intermediate Web Link

    Market Place

    368421-58-3
    Isavuconazonium Sulfate
    Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in S...
    Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities are located in China, Slovenia, the US, Belgium, Switzerland, Denmark, with more than 6000 employees worldwide. Porton leads the way with its excellent CDMO services, but also supplies APIs & intermediates for the treatment of critical diseases such as HIV/AIDS, diabetes, cancer, & influenza. Our Process Technology Centers & WHO/USFDA/EMA/PDMA/NMPA-inspected Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets.
    Porton Company Banner

    06

    (2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy- 2-Methyl-4-(1H-1,2,4-triazol-1-yl)thiobutyraMide

    China
    2024 ACI Convention
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothPorton Pharma Solutions: Value creation via innovation & discovery through technical platforms.

    Porton Pharma Solutions

    (2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy- 2-Methyl-4-(1H-1,2,4...

    CAS Number : 368421-58-3

    End Use API : Isavuconazonium Sulfate

    About the Company : Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchan...

    Porton Company Banner

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothPorton Pharma Solutions: Value creation via innovation & discovery through technical platforms.
    Contact Supplier Contact Supplier
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4- chloro-3-(4- ethoxybe...

    Intermediate Web Link

    Market Place

    461432-25-7
    Dapagliflozin
    Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in S...
    Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities are located in China, Slovenia, the US, Belgium, Switzerland, Denmark, with more than 6000 employees worldwide. Porton leads the way with its excellent CDMO services, but also supplies APIs & intermediates for the treatment of critical diseases such as HIV/AIDS, diabetes, cancer, & influenza. Our Process Technology Centers & WHO/USFDA/EMA/PDMA/NMPA-inspected Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets.
    Porton Company Banner

    07

    (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4- chloro-3-(4- ethoxybenzyl)phenyl)tetrah ydro-2H-pyran-3,4,5-triyltriacetate

    China
    2024 ACI Convention
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothPorton Pharma Solutions: Value creation via innovation & discovery through technical platforms.

    Porton Pharma Solutions

    (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4- chloro-3-(4- ethoxybe...

    CAS Number : 461432-25-7

    End Use API : Dapagliflozin

    About the Company : Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchan...

    Porton Company Banner

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothPorton Pharma Solutions: Value creation via innovation & discovery through technical platforms.
    Contact Supplier Contact Supplier
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    (2R,3S)-2-(2,5-difluorophenyl)-3-methyl-2- [(1H-1,2,4-triazol-...

    Intermediate Web Link

    Market Place

    241479-73-2
    Isavuconazonium Sulfate
    Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in S...
    Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities are located in China, Slovenia, the US, Belgium, Switzerland, Denmark, with more than 6000 employees worldwide. Porton leads the way with its excellent CDMO services, but also supplies APIs & intermediates for the treatment of critical diseases such as HIV/AIDS, diabetes, cancer, & influenza. Our Process Technology Centers & WHO/USFDA/EMA/PDMA/NMPA-inspected Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets.
    Porton Company Banner

    08

    (2R,3S)-2-(2,5-difluorophenyl)-3-methyl-2- [(1H-1,2,4-triazol-1-yl)- methyl]-oxirane

    China
    2024 ACI Convention
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothPorton Pharma Solutions: Value creation via innovation & discovery through technical platforms.

    Porton Pharma Solutions

    (2R,3S)-2-(2,5-difluorophenyl)-3-methyl-2- [(1H-1,2,4-triazol-...

    CAS Number : 241479-73-2

    End Use API : Isavuconazonium Sulfate

    About the Company : Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchan...

    Porton Company Banner

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothPorton Pharma Solutions: Value creation via innovation & discovery through technical platforms.
    Contact Supplier Contact Supplier
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    (3R,4S,5R,6R)-3,4,5-tris(triMethylsilyloxy)-6- ((triMethylsily...

    Intermediate Web Link

    Market Place

    32384-65-9
    Empagliflozin
    Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in S...
    Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities are located in China, Slovenia, the US, Belgium, Switzerland, Denmark, with more than 6000 employees worldwide. Porton leads the way with its excellent CDMO services, but also supplies APIs & intermediates for the treatment of critical diseases such as HIV/AIDS, diabetes, cancer, & influenza. Our Process Technology Centers & WHO/USFDA/EMA/PDMA/NMPA-inspected Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets.
    Porton Company Banner

    09

    (3R,4S,5R,6R)-3,4,5-tris(triMethylsilyloxy)-6- ((triMethylsilyloxy)Methyl)t etrahydro-2H-pyran-2-one

    China
    2024 ACI Convention
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothPorton Pharma Solutions: Value creation via innovation & discovery through technical platforms.

    Porton Pharma Solutions

    (3R,4S,5R,6R)-3,4,5-tris(triMethylsilyloxy)-6- ((triMethylsily...

    CAS Number : 32384-65-9

    End Use API : Empagliflozin

    About the Company : Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchan...

    Porton Company Banner

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothPorton Pharma Solutions: Value creation via innovation & discovery through technical platforms.
    Contact Supplier Contact Supplier
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    (3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-fu...

    Intermediate Web Link

    Market Place

    915095-94-2
    Empagliflozin
    Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in S...
    Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities are located in China, Slovenia, the US, Belgium, Switzerland, Denmark, with more than 6000 employees worldwide. Porton leads the way with its excellent CDMO services, but also supplies APIs & intermediates for the treatment of critical diseases such as HIV/AIDS, diabetes, cancer, & influenza. Our Process Technology Centers & WHO/USFDA/EMA/PDMA/NMPA-inspected Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets.
    Porton Company Banner

    10

    (3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan

    China
    2024 ACI Convention
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothPorton Pharma Solutions: Value creation via innovation & discovery through technical platforms.

    Porton Pharma Solutions

    (3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-fu...

    CAS Number : 915095-94-2

    End Use API : Empagliflozin

    About the Company : Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchan...

    Porton Company Banner

    Intermediate Web Link

    Market Place

    Contact Porton Pharma Solutions and get a quotation

    Porton Pharma Solutions is a supplier offers 32 products (APIs, Excipients or Intermediates).

    Find a price of Nicotine bulk with DMF, CEP offered by Porton Pharma Solutions

    Find a price of Alectinib Hydrochloride bulk with DMF offered by Porton Pharma Solutions

    Find a price of Apalutamide bulk with DMF offered by Porton Pharma Solutions

    Find a price of Baloxavir Marboxil bulk with DMF offered by Porton Pharma Solutions

    Find a price of Canagliflozin bulk with DMF offered by Porton Pharma Solutions

    Find a price of CAS 1421271-01-3 bulk with DMF offered by Porton Pharma Solutions

    Find a price of Dapagliflozin bulk with DMF offered by Porton Pharma Solutions

    Find a price of Darunavir Ethanolate bulk with DMF offered by Porton Pharma Solutions

    Find a price of Dexrazoxane bulk with DMF offered by Porton Pharma Solutions

    Find a price of Isavuconazonium Sulfate bulk with DMF offered by Porton Pharma Solutions

    Find a price of Mefloquine bulk with DMF offered by Porton Pharma Solutions

    Find a price of Nicotine bulk with DMF offered by Porton Pharma Solutions

    Find a price of Phloroglucinol bulk with DMF offered by Porton Pharma Solutions

    Find a price of Relugolix bulk with DMF offered by Porton Pharma Solutions

    Find a price of Salmeterol Xinafoate bulk with DMF offered by Porton Pharma Solutions

    Find a price of Sulfanilamide bulk with DMF offered by Porton Pharma Solutions

    Find a price of Tiopronin bulk with DMF offered by Porton Pharma Solutions

    Find a price of Vibegron bulk with DMF offered by Porton Pharma Solutions

    Find a price of TRIMETHYLPHLOROGLUCINOL DRUG SUBSTANCE (NON-STERILE) bulk with DMF offered by Porton Pharma Solutions

    Find a price of Abemaciclib bulk offered by Porton Pharma Solutions

    Find a price of Cariprazine Hydrochloride bulk offered by Porton Pharma Solutions

    Find a price of Crisaborole bulk offered by Porton Pharma Solutions

    Find a price of Dolutegravir Sodium bulk offered by Porton Pharma Solutions

    Find a price of Empagliflozin bulk offered by Porton Pharma Solutions

    Find a price of Hydroxychloroquine Sulphate bulk offered by Porton Pharma Solutions

    Find a price of Methotrexate bulk offered by Porton Pharma Solutions

    Find a price of Niraparib Tosylate bulk offered by Porton Pharma Solutions

    Find a price of Palbociclib bulk offered by Porton Pharma Solutions

    Find a price of Rimegepant Sulfate bulk offered by Porton Pharma Solutions

    Find a price of Ruxolitinib Phosphate bulk offered by Porton Pharma Solutions

    Find a price of Trimethyl Phloroglucinol bulk offered by Porton Pharma Solutions

    Find a price of Vonoprazan Fumarate bulk offered by Porton Pharma Solutions